印度的质子治疗市场:各产品类型，各适应症，各设定类型，各终端用户，各地区，机会，预测，2018年～2032年

预计在 2025 年至 2032 年的预测期内，印度质子治疗市场规模将以 10.00% 的复合年增长率扩大，从 2024 年的 2127 万美元增加到 2032 年的 4560 万美元。印度质子治疗市场的发展受到癌症发病率上升、医疗保健支出增加、癌症中心数量增加以及精准放射技术的进步的推动。此外，政府计划、认识的提高以及与国际医疗保健领袖的合作也在推动采用。此外，治疗的可负担性、医疗旅游以及对更安全、更有针对性的癌症治疗的需求不断增长也在推动市场扩张。

由于生活方式的改变、环境因素以及人口老化，癌症发生率不断上升，已成为印度主要的公共卫生问题。这种担忧促使政府和私营部门透过国家计划、早期检测计划和改善治疗机会的形式来加强医疗保健基础设施。在全国范围内建立新的癌症治疗中心对于改善患者护理至关重要。 2024 年 12 月，政府宣布将在科钦建立一个新的癌症中心，命名为科钦癌症研究中心 (CCRC)。该中心预计将于 2025 年 2 月至 5 月开始营运。此外，埃尔讷古勒姆政府医学院和医院 (MCH) 的专科大楼预计将于 2025 年 4 月完工。

此外，医院与研究机构和全球卫生当局的合作正在加速引进最新的肿瘤技术。对改进治疗方案的需求不断增长，以及患者和医疗保健专业人员的认识不断提高，正在加速印度质子治疗的发展。质子治疗市场专注于提供高精度、低毒性的癌症治疗，有望实现长期成长，提供重大的投资机会、基础设施发展和改善患者治疗效果的潜力。

本报告提供印度的质子治疗市场相关调查，提供市场概要，以及各产品类型，各适应症，各设定类型，各终端用户，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 摘要整理

第4章 印度的质子治疗市场预测，2018年～2032年

• 市场规模的分析与预测
• 市场占有率分析与预测
• 市场地图分析，2024年
  • 各产品类型
  • 各适应症
  • 各设定类型
  • 各终端用户
  • 各地区

第5章 需求供给分析

第6章 进出口的分析

第7章 价值链分析

第8章 波特的五力分析

第9章 大环境分析

第10章 价格分析

第11章 市场动态

第12章 市场趋势与发展

第13章 法规结构和革新

第14章 专利的形势

第15章 案例研究

第16章 竞争情形

• 前五名市场领导的竞争矩阵
• 前五名参与企业的SWOT分析
• 市场主要加入企业前五名的形势
  • Ion Beam Applications SA (IBA)
  • Varian Medical Systems International India Pvt. Ltd.
  • Mitsubishi Electric Corporation
  • Hitachi Ltd.
  • Elekta Medical Systems India Pvt. Ltd.
  • Mevion Medical Systems, Inc.
  • Optivus Proton Therapy, Inc.
  • ProTom International
  • Provision Solutions, LLC
  • Sumitomo Heavy Industries Ltd.

第17章 策略性建议

第18章 关于调查公司·免责声明

India proton therapy market is projected to grow at a CAGR of 10.00% from FY2025 to FY2032, increasing from USD 21.27 million in FY2024 to USD 45.60 million by FY2032. The proton therapy market in India is propelled by the rising cancer incidence, increased healthcare expenditure, growing cancer facilities, and advances in precision radiation technology. Furthermore, government programs, growing awareness, and partnerships with international healthcare leaders also drive adoption. Growing affordability, medical tourism, and demand for safer, targeted cancer treatment also support the market expansion.

Cancer is emerging as a major public health concern in India, with a rising incidence due to lifestyle changes, environmental exposures, and the aging of the population. In line with this concern, the government and private sectors are reinforcing healthcare infrastructure in the form of national programs, early detection programs, and better access to treatment. The establishment of new cancer treatment centers throughout the country is vital to the improvement of patient care. In December 2024, the government declared the opening of a new cancer center in Kochi to be established as the Cochin Cancer Research Centre (CCRC). This center is likely to be operational between February and May 2025. Furthermore, a specialized block of the Government Medical College Hospital (MCH) in Ernakulam is likely to be ready by April 2025.

Moreover, hospital partnerships with research institutions and global health authorities are assisting in the introduction of the newest oncology technologies. Increasing demand for improved treatment alternatives, along with increasing patient and medical professional awareness, is assisting in accelerating the development of proton therapy in India. With an emphasis on the provision of high-precision, low-toxicity cancer treatment, the proton therapy market is poised for long-term growth, with the potential to offer significant investment opportunities, infrastructure development, and improved patient outcomes in the country.

Increasing Research Activities Supports Market Expansion

India is developing its cancer research landscape by strengthening their R&D sector, with government efforts, research collaborations, and more funding. As the number of cancer patients grows, measures are being taken to enhance cancer management and treatment. One of the notable advancements is India's achievement in proton therapy accessibility. For example, in May 2023, a proton beam facility has been established at the Tata Memorial Centre's Kharghar campus, the first one in the public sector. The purpose is to facilitate treatment conveniently for cancer patients by offering free treatment to some needy patients while offering subsidized prices to other cancer patients. This is an effort to manage the rising numbers of cancer patients in India. In September 2024, Tata Memorial Centre (TMC) announced in-house research to maximize the utility of proton beam therapy, a cutting-edge radiation therapy for pediatric and adult cancers. TMC's Advanced Centre for Treatment Research & Education in Cancer (ACTREC) will collaborate with international researchers and assess which patient groups benefit the most from proton therapy. Such efforts in the country present promising expansion potential for the proton therapy market.

Rising Public Awareness Campaigns Boosting Market Growth

Rising public awareness of cancer and the treatment process is considerably propelling the proton therapy market growth. Some awareness campaigns in India focus on the importance of early detection, which leads to frequent screening and medical checkups. This proactive strategy leads to the prompt detection of cancers that can be treated with proton therapy and hence contributes to the increasing pool of patients for advanced care. In India, efforts toward making people aware about cancer and cognizant of the benefit of early detection are on a massive scale, thus propelling the growth of the proton therapy market. Large-scale cancer care centers are conducting awareness programs. For instance, in October 2024, the Apollo Cancer Centre conducted the "Men in Pink Walkathon" in Chennai, urging men to raise their voices for breast cancer screening among women in their lives. Such activities stimulate a stir about early detection, in the process creating the need for proton therapy.

Hospitals Holding the Major Shares of the Proton Therapy Market

India's hospital sector is at the forefront of the increasing demand for proton therapy as hospitals are the primary end-users of this new-generation cancer treatment. The trend is expected to continue during the forecast period with the increasing prevalence of cancer, increasing expenditure on healthcare infrastructure, and extensive adoption of new advanced medical technologies. Some of India's top hospitals, such as Apollo Cancer Care Centre, Tata Memorial Centre, and AIG Hospitals, have recently added proton therapy to their treatment facilities. These hospitals are also trying to make it more affordable so that more patients can take advantage of this new generation of technology. Launch of such specialized facilities is proving to be a key factor in improving cancer treatment outcomes in the country. Also, the Indian government is putting efforts to make proton therapy more cost-effective and available in the country. India provides this treatment at a lower cost as compared to many Western countries, which makes it a desirable choice for individuals seeking advanced cancer treatment. Moreover, the growing awareness among individuals is reflected by the rise in the number of specialized centers and government-supported schemes to make the cost more affordable. Due to this, demand for proton therapy in India is increasing at a very fast pace, driving market growth and making India one of the foremost destinations for advanced cancer treatment.

Future Market Scenario (FY2025 -FY2032F)

India's proton therapy market will experience robust growth, owing to growing adoption and expanding infrastructure. Since 2019, Apollo Proton Cancer Centre (APCC) has seen over 1,200 patients with pencil beam scanning technology for various cancers. Tata Memorial Center's government-funded center is expanding access too. Awareness, technological advancements, and government policies are primary drivers. Increasingly, proton therapy will become an established component of India's cancer care, as acceptance increases and results improve.

Furthermore, developments in India's healthcare industry and technological advancements are driving the growth of proton therapy. In January 2025, AIG Hospital in Hyderabad installed DynamicARC proton therapy, the first to be equipped in Southeast Asia. The achievement is a testament to its mission of making advanced, efficient, and affordable cancer treatment for Indian patients and setting a new benchmark in the region. Investments in cancer centers are increasing, accessibility has been enhanced, and awareness has picked up pace, driving adoption. Advanced facilities and collaborations are enhancing precision medicine, driving market expansion, and enhanced patient access.

Key Players Landscape and Outlook

The competitive landscape of proton therapy in India is changing, with significant players looking to strengthen their positions through strategic partnerships with hospitals. Proton therapy companies are raising awareness and creating more education about the benefits of proton therapy in healthcare institutions. Investments in advanced technology, expanding treatment centers, and partnerships with research organizations further drive growth. These strategies, thereby improving access in addition to developing providers as experts in their specializations, will respond to a growing demand for advanced cancer treatment in India.

In July 2023, Ion Beam Applications SA (IBA) and Apollo Proton Cancer Centre partnered to offer proton beam therapy training, and India is now the first in Southeast Asia to offer it to international oncologists. This strategic move enhances IBA's leadership in the Asian market by offering high-end proton therapy training and education programs to its customers, further cementing its dedication to innovation and excellence in cancer treatment.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Proton Therapy Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. Systems
      • 4.2.1.1.1. Cyclotron
      • 4.2.1.1.2. Synchrotron
      • 4.2.1.1.3. Synchrocyclotron
    • 4.2.1.2. Services
  • 4.2.2. By Indications
    • 4.2.2.1. Head and Neck Cancer
    • 4.2.2.2. Central Nervous System Cancer
    • 4.2.2.3. Prostate Cancer
    • 4.2.2.4. Breast Cancer
    • 4.2.2.5. Lung Cancer
    • 4.2.2.6. Pediatric Cancer
    • 4.2.2.7. Gastrointestinal Cancer
    • 4.2.2.8. Others
  • 4.2.3. By Setup Type
    • 4.2.3.1. Single-Room Systems
    • 4.2.3.2. Multi-Room Systems
  • 4.2.4. By End-user
    • 4.2.4.1. Hospitals
    • 4.2.4.2. Proton Therapy Centers
    • 4.2.4.3. Cancer Centers or Institutes
  • 4.2.5. By Region
    • 4.2.5.1. North
    • 4.2.5.2. South
    • 4.2.5.3. East
    • 4.2.5.4. West and Central
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product Type
  • 4.3.2. By Indications
  • 4.3.3. By Setup Type
  • 4.3.4. By End-user
  • 4.3.5. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

• 13.1. Regulatory Approvals
• 13.2. Developments and Innovations

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 5 Market Players
  • 16.3.1. Ion Beam Applications SA (IBA)
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 16.3.2. Varian Medical Systems International India Pvt. Ltd.
  • 16.3.3. Mitsubishi Electric Corporation
  • 16.3.4. Hitachi Ltd.
  • 16.3.5. Elekta Medical Systems India Pvt. Ltd.
  • 16.3.6. Mevion Medical Systems, Inc.
  • 16.3.7. Optivus Proton Therapy, Inc.
  • 16.3.8. ProTom International
  • 16.3.9. Provision Solutions, LLC
  • 16.3.10. Sumitomo Heavy Industries Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Proton Therapy Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Proton Therapy Market, By Volume, In Million Units, FY2018-FY2032F
• Figure 3. India Proton Therapy Market Share (%), By Product Type, FY2018-FY2032F
• Figure 4. India Proton Therapy Market Share (%), By Indications, FY2018-FY2032F
• Figure 5. India Proton Therapy Market Share (%), By Setup Type, FY2018-FY2032F
• Figure 6. India Proton Therapy Market Share (%), By End-user, FY2018-FY2032F
• Figure 7. India Proton Therapy Market Share (%), By Region, FY2018-FY2032F
• Figure 8. By Product Type Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Indications Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By Setup Type Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 11. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 12. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024